Recently, Dussold et al. demonstrated the osteocyte protein dentin matrix protein 1 (DMP1) as a feasible therapeutic target to control FGF23 levels and improve cardiac and bone health in CKD patients. Here, DMP1 is linked to chronic kidney disease.